Filtros de búsqueda

Lista de obras de Muntasir Mamun Majumder

Dasatinib and navitoclax act synergistically to target NUP98-NSD1+/FLT3-ITD+ acute myeloid leukemia

scientific article published on 19 December 2018

Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer

scientific article published on 20 May 2019

Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling

artículo científico publicado en 2017

Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML

artículo científico publicado en 2016

HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia.

artículo científico publicado en 2016

Homologous recombination repairs secondary replication induced DNA double-strand breaks after ionizing radiation.

artículo científico publicado en 2012

Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia

artículo científico publicado en 2016

Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testing

artículo científico publicado en 2017

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

artículo científico publicado en 2013

JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML.

artículo científico publicado en 2017

Methylated DNA causes a physical block to replication forks independently of damage signalling, O(6)-methylguanine or DNA single-strand breaks and results in DNA damage.

artículo científico publicado en 2010

Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients

artículo científico publicado en 2021

Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia

artículo científico publicado en 2014

Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing

artículo científico publicado en 2015

Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies

artículo científico publicado en 2014

S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma

artículo científico publicado en 2021

Somatic STAT3 mutations in large granular lymphocytic leukemia ⬇️

artículo científico publicado en 2012

The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda